Buffer Therapy for Cancer

Maria De Lourdes C. Ribeiro^1,4, Ariosto S. Silva¹, Kate M. Bailey^1,5, Nagi B. Kumar², Thomas A. Sellers², Robert A. Gatenby³, Arig Ibrahim-Hashim¹ and Robert J. Gillies^1,3*

¹Department of Cancer Imaging and Metabolism, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA, E-mail: MariadeLourdesRibeiro@gmail.com

²Department of Epidemiology and Population Sciences Division, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA, E-mail: MariadeLourdesRibeiro@gmail.com

³Department of Radiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA, E-mail: MariadeLourdesRibeiro@gmail.com

⁴Department of Molecular Medicine, Biotechnology M.S. Program, University of South Florida, Tampa, FL 33612, USA, E-mail: MariadeLourdesRibeiro@gmail.com

⁵Department of Cell Biology, Microbiology, and Molecular Biology, Cancer Biology Ph.D. Program, University of South Florida, Tampa, FL 33612, USA, E-mail: MariadeLourdesRibeiro@gmail.com

^*Corresponding Author: Robert J. Gillies, Senior Member, H. Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive SRB-4, Tampa, Florida 33612, USA, Tel: (813) 745-8355, Fax: (813) 745-7265